tradingkey.logo

Bio-Techne advances on better-than-expected quarterly results

ReutersFeb 4, 2026 3:32 PM

Shares of Bio-Techne TECH.O rise 4.54% to $67.57

The biotech firm reports Q2 revenue of $295.9 million, beating average of analysts' estimates of $290.2 million, as per data compiled by LSEG

Posts adjusted quarterly profit of 46 cents per share, above average estimate of 43 cents

*"We expect a recovery in the pharma end-market and biotech funding to support some growth in the coming quarters," Leerink Partners analysts said in a note

TECH slumped 18.35% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI